The link between CYP1A2 and blood sugar is not directly supported by the provided context. CYP1A2 is primarily known for metabolizing caffeine. Caffeine can transiently raise blood glucose by reducing insulin sensitivity. Individuals with a slow-metabolizing CYP1A2 variant (e.g., *1F) may experience more pronounced glucose spikes after caffeine. However, evidence for a clinically meaningful impact on fasting glucose or diabetes risk is limited. The provided context lacks specific studies on CYP1A2 and blood sugar. Lifestyle factors such as diet, exercise, and sleep have far greater influence. A DNA test can indicate a tendency but does not replace actual blood glucose measurements. Caution against overinterpretation: effects are small and individual.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-9e1922d1b315600b050d291d